P
Pantep Angchaisuksiri
Researcher at Mahidol University
Publications - 111
Citations - 5555
Pantep Angchaisuksiri is an academic researcher from Mahidol University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 31, co-authored 93 publications receiving 3972 citations.
Papers
More filters
Journal ArticleDOI
Thrombosis A Major Contributor to Global Disease Burden
Gary E. Raskob,Pantep Angchaisuksiri,Alicia N. Blanco,Harry R. Büller,Alexander Gallus,Beverley J. Hunt,Elaine M. Hylek,Ajay K. Kakkar,Stavros Konstantinides,M. McCumber,Yukio Ozaki,Aaron M. Wendelboe,Jeffrey I. Weitz +12 more
TL;DR: A systematic review of the literature on the global burden of venous thromboembolism (VTE) in low-, middle-, and high-income countries was performed in this article.
Journal Article
Thrombosis: a major contributor to the global disease burden
Gary E. Raskob,Pantep Angchaisuksiri,Alicia N. Blanco,H. R. Büller,Alexander Gallus,Beverley J. Hunt,Elaine M. Hylek,A. K. Kakkar,Stavros Konstantinides,Micah McCumber,Yukio Ozaki,Aaron M. Wendelboe,J. I. Weitz +12 more
TL;DR: VTE associated with hospitalization was the leading cause of disability-adjusted life-years lost in low- and middle- income countries, and second in high-income countries, responsible for more disability- adjusted life- years lost than nosocomial pneumonia, catheter-related blood stream infections, and adverse drug events.
Journal ArticleDOI
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.
Dominique Farge,Dominique Farge,Corinne Frere,Jean M. Connors,Cihan Ay,Alok A. Khorana,Andrés Muñoz,Benjamin Brenner,Ajay K. Kakkar,Hanadi Rafii,Susan Solymoss,Dialina Brilhante,Manuel Monreal,Henri Bounameaux,Ingrid Pabinger,James D. Douketis,Walter Ageno,Fernando Ajauro,Kamal R. Al-Aboudi,Thierry Alcindor,Thierry André,Pantep Angchaisuksiri,Darko Antic,Juan I. Arcelus,Eric Assenat,Kenneth A. Bauer,Ali Bazarbachii,I. Benzidia,Jan Beyer-Westendorf,Viktoria Bitsadze,Dorit Blickstein,Mark Blostein,Isabel Bogalho,Barbara Bournet,Patricia Casais,Antoine F. Carpentier,Gabriela Cesarman-Maus,Joydeep Chakbrabartty,Hugo A. Clemente,Jérôme Connault,Ludovic Doucet,Cécile Durant,Joseph Emmerich,Anna Falanga,Clemens Feistritzer,Carme Font,Charles W. Francis,Enrique Gallardo,Thomas Gary,Jean-Christophe Gris,Cecilia Guillermo,A. Hij,Russel D. Hull,Takayuki Ikezoe,Luis Jara-Palomares,Nigel S. Key,Jamilya Khrizroeva,Maral Koolian,Florian Langer,Ramón Lecumberri,Lai Heng Lee,Howard A. Liebman,Luisa Lopes Dos Santos,Duarte Henrique Machado,Isabelle Madelaine,Alexander Makatsariya,Mario Mandalà,Anthony Marayevas,Zora Marjanovic,Christine Marosi,Ellis Martin,Luis Meillon,Emmanuel Messas,Antonio Moreira,Ahmet M. Demir,Arlette Ndour,Michel Nguessan,Remedios Otero-Candelera,Vanessa Pachon Olmos,Ana Pais,Florian Posch,Matthias Preusser,Hanno Riess,Marc Philip Righini,Cynthia Rothschild,Andre Roussin,José Antonio Rueda-Camino,Pedro Ruiz-Artacho,Sanjith Saseedharan,Ali Shamseddine,Gerald A. Soff,Hans Stricker,Vicky Tagalakis,Ali T. Taher,Toutou Toussaint,Javier Trujillo-Santos,Stéphane Villiers,Raymond S.M. Wong,Norizaku Yamada +98 more
TL;DR: The 2019 International Initiative on Thrombosis and Cancer clinical practice guidelines, which are based on a systematic review of the literature published up to December, 2018, are presented along with a Grading of Recommendations Assessment Development and Evaluation scale methods.
Journal ArticleDOI
Thrombosis: a major contributor to global disease burden
Gary E. Raskob,Pantep Angchaisuksiri,Alicia N. Blanco,Harry R. Büller,Alexander Gallus,Beverley J. Hunt,Elaine M. Hylek,Stavros Konstantinides,Micah McCumber,Yukio Ozaki,Aaron M. Wendelboe,Jeffrey I. Weitz +11 more
TL;DR: VTE associated with hospitalization was the leading cause of disability-adjusted-life-years lost in low- and middle-income countries, and second in high- income countries, responsible for more DALYs lost than nosocomial pneumonia, catheter-related blood stream infections, and adverse drug events.
Journal ArticleDOI
American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19.
Adam Cuker,Eric Tseng,Robby Nieuwlaat,Robby Nieuwlaat,Pantep Angchaisuksiri,Clifton Blair,Kathryn Dane,Jennifer Davila,Maria T. DeSancho,David L. Diuguid,Daniel O. Griffin,Susan R. Kahn,Frederikus A. Klok,Alfred Ian Lee,Ignacio Neumann,Ashok Pai,Menaka Pai,Marc Philip Righini,Kristen M. Sanfilippo,Deborah M. Siegal,Mike Skara,Kamshad Touri,Elie A. Akl,Imad Bou Akl,Mary Boulos,Romina Brignardello-Petersen,Rana Charide,Matthew T. V. Chan,Karin Lee Dearness,Andrea Darzi,Andrea Darzi,Philipp Kolb,Luis Enrique Colunga-Lozano,Razan Mansour,Gian Paolo Morgano,Gian Paolo Morgano,Rami Z. Morsi,Atefeh Noori,Thomas Piggott,Yuan Qiu,Yetiani Roldan,Finn Schünemann,Adrienne Stevens,Adrienne Stevens,Karla Solo,Karla Solo,Matthew Ventresca,Matthew Ventresca,Wojtek Wiercioch,Wojtek Wiercioch,Reem A. Mustafa,Holger J. Schünemann +51 more
TL;DR: The evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians, and other health care professionals in decisions about the use of anticoagulation for thromboprophylaxis for patients with COVID-19-related critical illness and acute illness who do not have confirmed or suspected venous thromboembolism (VTE) as mentioned in this paper.